Your browser doesn't support javascript.
loading
AMYPAD Diagnostic and Patient Management Study: Rationale and design.
Frisoni, Giovanni B; Barkhof, Frederik; Altomare, Daniele; Berkhof, Johannes; Boccardi, Marina; Canzoneri, Elisa; Collij, Lyduine; Drzezga, Alexander; Farrar, Gill; Garibotto, Valentina; Gismondi, Rossella; Gispert, Juan-Domingo; Jessen, Frank; Kivipelto, Miia; Lopes Alves, Isadora; Molinuevo, José Luis; Nordberg, Agneta; Payoux, Pierre; Ritchie, Craig; Savicheva, Irina; Scheltens, Philip; Schmidt, Mark E; Schott, Jonathan M; Stephens, Andrew; van Berckel, Bart; Vellas, Bruno; Walker, Zuzana; Raffa, Nicola.
Afiliação
  • Frisoni GB; Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland; Memory Clinic, University Hospital of Geneva, Geneva, Switzerland; Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), Saint John of God Clinical Research Centre, Brescia, Italy. Electronic address:
  • Barkhof F; Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, the Netherlands; Institutes of Neurology and Healthcare Engineering, UCL, London, United Kingdom.
  • Altomare D; Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), Saint John of God Clinical Research Centre, Brescia, Italy; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
  • Berkhof J; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands.
  • Boccardi M; Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland; Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), Saint John of God Clinical Research Centre, Brescia, Italy.
  • Canzoneri E; Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
  • Collij L; Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, the Netherlands.
  • Drzezga A; Department of Nuclear Medicine, University Hospital of Cologne, University of Cologne and German Center for Neurodegenerative Diseases (DZNE), Germany.
  • Farrar G; Life Sciences, GE Healthcare, Amersham, Buckinghamshire, United Kingdom.
  • Garibotto V; Division of Nuclear Medicine and Molecular Imaging, Department of Medical Imaging, University Hospitals of Geneva, Geneva, Switzerland; NIMTlab, Faculty of Medicine, Geneva University, Geneva, Switzerland.
  • Gismondi R; Piramal Imaging, Medical Affairs, Berlin, Germany.
  • Gispert JD; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.
  • Jessen F; Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Kivipelto M; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden; Aging Theme, Karolinska University Hospital Stockholm, Sweden; University of Eastern Finland, Finland; School of Public Health, Imperial Co
  • Lopes Alves I; Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, the Netherlands.
  • Molinuevo JL; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain.
  • Nordberg A; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden; Aging Theme, Karolinska University Hospital Stockholm, Sweden.
  • Payoux P; Nuclear Medicine Department, University Hospital of Toulouse (CHU-Toulouse), Toulouse, France; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.
  • Ritchie C; Centre for Clinical Brain Sciences, Department of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
  • Savicheva I; Nuclear Medicine IRA, Medical Radiation Physics and Nuclear Medicine Imaging, Karolinska University Hospital, Sweden.
  • Scheltens P; Alzheimer Center and Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, the Netherlands.
  • Schmidt ME; Experimental Medicine, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Schott JM; Institute of Neurology, University College London, London, United Kingdom.
  • Stephens A; Piramal Imaging, Clinical Research and Development, Berlin, Germany.
  • van Berckel B; Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, the Netherlands.
  • Vellas B; Gerontopole of Toulouse, University Hospital of Toulouse (CHU-Toulouse), Toulouse, France; UMR INSERM 1027, University of Toulouse III, Toulouse, France.
  • Walker Z; Division of Psychiatry, University College London, London, United Kingdom; Essex Partnership University NHS Foundation Trust, United Kingdom.
  • Raffa N; Piramal Imaging, Market Access and HEOR, Berlin, Germany.
Alzheimers Dement ; 15(3): 388-399, 2019 03.
Article em En | MEDLINE | ID: mdl-30339801

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Tomografia por Emissão de Pósitrons / Doença de Alzheimer / Disfunção Cognitiva / Amiloide Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Alzheimers Dement Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Tomografia por Emissão de Pósitrons / Doença de Alzheimer / Disfunção Cognitiva / Amiloide Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Alzheimers Dement Ano de publicação: 2019 Tipo de documento: Article